PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China.\', \'The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, P. R. China.\', \'Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P. R. China.\', \'Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China.\', \'Department of Pathology, North Lantau Hospital, Hong Kong, P. R. China.\', \'Laboratory of Data Discovery for Health Limited, Hong Kong Science Park, Hong Kong, P. R. China.\', \'Centre for Immunology and Infection, Hong Kong Science Park, Hong Kong, P. R. China.\', \'Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong, Kong, Hong Kong, P. R. China. dschui@cuhk.edu.hk.\', \'Stanley Ho Centre for Emerging Infectious Diseases, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, P. R. China. dschui@cuhk.edu.hk.\', \'School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, P. R. China. malik@hku.hk.\', \'Centre for Immunology and Infection, Hong Kong Science Park, Hong Kong, P. R. China. malik@hku.hk.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41591-022-01704-7
?:doi
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 35051989
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
?:title
  • Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all